Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

244 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin?
Chiloiro S, Giampietro A, Bianchi A, Menotti S, Angelini F, Tartaglione T, Antonini Cappellini GC, De Galitiis F, Rossi E, Schinzari G, Scoppola A, Pontecorvi A, De Marinis L, Fleseriu M. Chiloiro S, et al. Among authors: fleseriu m. J Pers Med. 2023 Feb 26;13(3):415. doi: 10.3390/jpm13030415. J Pers Med. 2023. PMID: 36983597 Free PMC article.
Pasireotide versus octreotide in acromegaly: a head-to-head superiority study.
Colao A, Bronstein MD, Freda P, Gu F, Shen CC, Gadelha M, Fleseriu M, van der Lely AJ, Farrall AJ, Hermosillo Reséndiz K, Ruffin M, Chen Y, Sheppard M; Pasireotide C2305 Study Group. Colao A, et al. Among authors: fleseriu m. J Clin Endocrinol Metab. 2014 Mar;99(3):791-9. doi: 10.1210/jc.2013-2480. Epub 2014 Jan 13. J Clin Endocrinol Metab. 2014. PMID: 24423324 Free PMC article. Clinical Trial.
Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol.
Newell-Price J, Fleseriu M, Pivonello R, Feelders RA, Gadelha MR, Lacroix A, Witek P, Heaney AP, Piacentini A, Pedroncelli AM, Biller BMK. Newell-Price J, et al. Among authors: fleseriu m. J Endocr Soc. 2024 Nov 12;9(1):bvae201. doi: 10.1210/jendso/bvae201. eCollection 2024 Nov 26. J Endocr Soc. 2024. PMID: 39610378 Free PMC article.
Higher risk and earlier onset glaucoma in Cushing's syndrome.
Sharon Y, Shochat T, Rudman Y, Kushnir S, Zahavi A, Shimon I, Fleseriu M, Akirov A. Sharon Y, et al. Among authors: fleseriu m. Acta Ophthalmol. 2024 Nov 5. doi: 10.1111/aos.16787. Online ahead of print. Acta Ophthalmol. 2024. PMID: 39498529
Osilodrostat treatment in patients with Cushing's disease of Asian or non-Asian origin: a pooled analysis of two Phase III randomized trials (LINC 3 and LINC 4).
Shimatsu A, Biller BM, Fleseriu M, Pivonello R, Lee EJ, Leelawattana R, Kim JH, Walia R, Yu Y, Liao Z, Piacentini A, Pedroncelli AM, Snyder PJ. Shimatsu A, et al. Among authors: fleseriu m. Endocr J. 2024 Dec 2;71(12):1103-1123. doi: 10.1507/endocrj.EJ24-0153. Epub 2024 Aug 23. Endocr J. 2024. PMID: 39183039 Free article. Clinical Trial.
244 results